Latest MS research news

Latest MS research news | 26 March 2013

Cognitive impairment differs between primary progressive and relapsing-remitting MS

The main finding in this study is the difference in frequency and severity of cognitive impairment between PPMS and RRMS patient groups. Patients with PPMS were more frequently impaired in executive function and verbal episodic memory

From MSIF

Latest MS research news | 19 March 2013

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

In this study from the UK, the researchers looked at identifying differences in MRI brain lesion distribution between aquaporin-4 antibody-positive NMOSD (neuromyelitis optica and its spectrum disorder) and RRMS, using quantitative lesion mapping.

From MSIF

Latest MS research news | 19 March 2013

Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology

The researchers looked at a post-mortem cohort of pathologically confirmed cases with multiple sclerosis with fresh frozen material for genetic analysis and fixed material for pathology.

From MSIF

Latest MS research news | 19 March 2013

The changing clinical course of multiple sclerosis: A matter of grey matter

This study from Italy developed a five year longitudinal study looking at demographic, clinical and MRI parameters that could predict the changing clinical course of MS.

From MSIF

Latest MS research news | 12 March 2013

White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI

The researchers looked at the relationship between lesions within the cerebral white matter (WM) and atrophy within the deep grey matter (GM) in MS.

From MSIF

Latest MS research news | 12 March 2013

Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions

This study group from the Netherlands looked at the extent and severity of white matter (WM) damage, using diffusion tensor imaging (DTI), to distinguish cognitively preserved (CP) from cognitively impaired (CI) ...

From MSIF

Latest MS research news | 12 March 2013

A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis

This research group looked at a new IPS test called the Computerised Speed Cognitive Test (CSCT), which can be easily administered in daily clinical practice for testing IPS impairment.

From MSIF

Latest MS research news | 05 March 2013

Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis

In this study from the US, the researchers investigated if fetuin-A is an indicator of disease activity.

From MSIF

Latest MS research news | 05 March 2013

The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?

This study group from Austria assessed the discriminatory value of the “central vein sign” (CVS) in a subset of patients where the susceptibility weighted imaging (SWI) feature may ...

From MSIF

Latest MS research news | 05 March 2013

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

In this randomised controlled trial, the researchers looked at the effects of oral teriflunomide on MS pathology by MRI. 1088 RRMS patients were randomised to teriflunomide 7mg or 24mg once daily or placebo for 108 weeks.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial